As a Biotechnology Consultant, I am entrusted with a variety of strategic and operational responsibilities, aimed at driving innovation and efficiency within the organization.My expertise includes:Strategic Consulting - Collaborating with executive leadership to develop and implement strategic plans, conducting market analysis, identifying emerging trends, and optimizing project portfolios. Clinical Development - regulatory compliance, developing and executing clinical development plans, and evaluating clinical data to support decision-making. Resource Optimization - Assessing capabilities of resource-constrained organizations, developing strategies to increase bandwidth, optimizing resource allocation, and implementing process improvements. Cross-functional Collaboration - Working closely with R&D teams, business development, marketing, and sales teams to integrate scientific and commercial strategies, driving product adoption and market penetration.I also enjoy advising founders and startups by providing guidance on experimental design, commercialization strategies, and personnel management, as well as facilitating industry connections.

Investing and advising awesome companies.

At Jumpcode I was an early hire and charged with hiring, building, developing and leading the wet and dry lab R&D teams. I was also responsible for all aspects of R&D budget, strategy, timeline tracking and cross-functional communication.

• Aid in developing business strategy and orchestrate development of products and services to meet strategic goals.• Guide and assess tactical scientific efforts in support of strategic goals.• Conceptualize, design, and drive new product development • Provide critical assessment, budgeting, and fiscal analysis of R&D efforts.• Coordinate efforts across wet-lab and analysis teams to meet operational and R&D goals and metrics.• Provide molecular and bioinformatics technical support to business development efforts.• Act as scientific point of contact for all contract pharmaceutical clients.• Recruit, interview, hire new talent, supervise and develop employees.

• Aid in corporate strategy development and communicate to align personnel with company’s goals.• Develop and drive performance measures across all operational units.• Coordinate efforts across sales, wet-lab and analysis teams to meet operational goals and metrics.• Define efficient and effective pricing targets and margins across all product categories and lead quarterly pricing audits against cost of goods.• Forecast and establish sales targets for sequencing products and services.• Manage company certified partner network to provide flex-sequencing capacity.• Recruit, interview, hire new talent, supervise and develop employees.

Swift Biosciences is a fast-moving company focused on developing enabling technologies and products for genomics and personalized medicine. Our technologies provide customers with powerful new methods to examine disease-related genes.

• Co-developed and transferred to production a novel capture method, Washington University Capture (WUCap). The WUCap method was instrumental in the completion of Pilot 3 of the The Cancer Genome Atlas Project (TCGA).• Project managed, beta-tested, and refined wet-lab procedures for Agilent Technologies SureSelect, Roche SeqCap, and RainDance Technologies RDT 1000 platforms.• Developed a sub-picogram whole genome amplification procedure used for characterization of bacterial pools for the Human Microbiome Project.• Designed a polymerase chain reaction (PCR) multilocus sequence typing (MLST) test for methicillin resistant Staphylococcus aureus resulting in multiple peer-reviewed publications.• Alpha- and beta-tested all aspects, including wet-lab, hardware, and software of the Roche (454), Illumina (Solexa), and Life Technologies (Applied Biosystems) next-generation sequencing platforms prior to commercialization; participation led to protocol optimizations and improvement of workflow bottlenecks.• Developed Chromosome 2, 7, and 11 bacterial artificial chromosome (BAC) arrays, which led to the discovery of del(2) progression factor in Acute Promyelocytic Leukemia (APL).• Designed and developed the Washington University C. elegans Whole Genome Oligo Array (http://www.ebi.ac.uk/arrayexpress/arrays/A-GEOD-9458/) providing researchers a previously unavailable resource. This array has sold thousands of units to date.• Led the development and testing of new techniques for microarray fabrication and probe design overcoming technical challenges and developing best practices for consistent manufacture and optimal performance.